Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 22Prostatic Neoplasms 21Glioblastoma 19Lung Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Rectal Neoplasms 12Glioma 12Neoplasms 11Oropharyngeal Neoplasms 10Head and Neck Neoplasms 10Esophageal Neoplasms 8Astrocytoma 8Sarcoma 7Neoplasm Metastasis 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Colorectal Neoplasms 6Carcinoma, Squamous Cell 6Brain Neoplasms 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Lymphoma, Follicular 5Hodgkin Disease 5Gliosarcoma 5Carcinoma, Hepatocellular 5Carcinoma 5Burkitt Lymphoma 5

Interventions

Nivolumab 7cabozantinib 5Specimen Handling 5Ipilimumab 5CTLA-4 Antigen 4Magnetic Resonance Spectroscopy 2sodium-iodide symporter 1sitravatinib 1lenvatinib 1fludarabine 1Zoledronic Acid 1Tissue Banks 1Radiotherapy 1Radiopharmaceuticals 1Pluvicto 1Ibandronic Acid 1Everolimus 1Diphosphonates 1Denosumab 1Blood Specimen Collection 1Biopsy 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Radiotherapy × 90 days × Clear all
NCT07043608 2026-05-01

ZAMBONI

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡